Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
available to download here . Baron Health Care Fund (the Fund) declined 6.97% (Institutional Shares) in the quarter, compared to the 4.88% decline for the Russell 3000 Health Care Index (the Benchmark) and the 3.96% decline for the Russell 3000 Index (the Index). The Fund appreciated 9.39% on an annualized basis since its inception, compared to the 8.97% gain for the Benchmark and the 13.26% gain for the Index. The disappointing stock selection drove the Fund's underperformance in the quarter. Despite recent challenges, the Fund believes the long-term outlook for health care remains positive due to factors including an aging population, rising chronic disease rates, advances in biotechnology, and increased health care spending. In addition, please check the Fund's top five holdings to know its best picks in 2026. In its first-quarter 2026 investor letter, Baron Health Care Fund highlighted Eli Lilly and Company (NYSE: LLY ). Eli Lilly and Company (NYSE:LLY) is a leading pharmaceutic
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket [MSNBC.com]MSNBC.com
- Eli Lilly CEO David Ricks on Q1 results, Zepbound-Mounjaro sales growth and launch of Foundayo pill [CNBC]CNBC
- Watch CNBC's full interview with Eli Lilly CEO David Ricks [CNBC]CNBC
- Eli Lilly (NYSE:LLY) Delivers Strong Q1 CY2026 Numbers, Stock Soars [Yahoo! Finance]Yahoo! Finance
- Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/26 - Beat
LLY
Sec Filings
- 4/30/26 - Form 8-K
- 4/29/26 - Form PX14A6G
- 4/21/26 - Form 4
- LLY's page on the SEC website